Octreotide acetate product-specific bioequivalence guidance
HumanScientific guidelines
This document provides product-specific guidance on the demonstration of the bioequivalence of octreotide acetate depot powder and solvent for suspension for injection 10 mg, 20 mg or 30 mg.
Keywords: Bioequivalence, generics, octreotide
Abbreviations: